Monday, 11 September 2023 | 23:04 WIB
Antara/WDP
Illustration of Covid-19 vaccination for children.
Jakarta, Beritasatu.com – Dengue hemorrhagic fever (DHF) vaccine or what is known as trivalent dengue vaccine (TDV) has received a distribution permit since 2022 from the Food and Drug Supervisory Agency (BPOM).
This was explained by the Chair of the Adult Immunization Task Force of the Association of Indonesian Internal Medicine Specialists (Papdi), Sukamto Koesnoe.
“TDV has received a distribution permit from BPOM since 2022, which indicates that this vaccine has gone through various stages of research, namely phase one, phase two and phase three, producing various evidence, one of which is evidence of safety,” said Sukamto to the media. Sunday (10/9/2023).
Sukamto explained that the efficacy of the TDV vaccine available in Indonesia is around 80%, this level can be achieved after a person receives two vaccinations according to the specified dose.
According to World Health Organization (WHO), vaccine efficacy refers to the ability of a vaccine to provide benefits for vaccinated individuals, namely benefits in maintaining health and protecting against dangerous diseases.
“The requirements for dengue fever vaccination must be carried out when the body is in good health and without allergies to vaccines. This vaccination is available for individuals aged between 6 to a maximum of 45 years, with two doses of vaccination that must be received,” explained Sukamto.
While in several other countries, TDV can be given to individuals up to the age of 60 years, in Indonesia currently the distribution permit granted by BPOM limits the use of this vaccine to only 45 years of age.
Sukamto also reminded that, similar to other vaccines, individuals with weak or inhibited immune systems are not recommended to receive this vaccination. If there is any doubt, it is advisable to consult a doctor first.
“Everyone who is in good health can receive this vaccine, but individuals who are taking immune system suppressing drugs, such as immunosuppressants“, or those who have a genetically weakened immune system, should not be given this vaccine,” he added.
Sukamto also stated that TDV is safe to give to individuals who have previously been infected with dengue fever and those who have never been infected.
Currently, TDV is available in various health facilities, both government and private. The price for one dose is around IDR 500,000, and to achieve maximum efficacy two doses or two vaccinations are needed. Of course it costs IDR 1 million to achieve the appropriate dose.
2023-09-11 16:04:52
#vaccinated #dengue #fever #prepare #budget #IDR #million